|
|
|
Volumn 15, Issue 6, 1997, Pages 9-12
|
|
Clinical profile of the novel angiotensin II type I blocker candesartan cilexetil
|
|
Author keywords
Angiotensin II; Angiotensin II receptor antagonist; Candesartan cilexetil; Hypertension; Trials
|
|
Indexed keywords
AMLODIPINE;
ANGIOTENSIN 2 RECEPTOR ANTAGONIST;
ANTIHYPERTENSIVE AGENT;
CANDESARTAN HEXETIL;
ENALAPRIL;
HYDROCHLOROTHIAZIDE;
LOSARTAN;
ANTIHYPERTENSIVE ACTIVITY;
BORDERLINE HYPERTENSION;
CLINICAL TRIAL;
CONFERENCE PAPER;
DIASTOLIC BLOOD PRESSURE;
DOUBLE BLIND PROCEDURE;
DRUG TOLERABILITY;
ESSENTIAL HYPERTENSION;
HUMAN;
HYPERTENSION;
META ANALYSIS;
MULTICENTER STUDY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SIDE EFFECT;
SYSTOLIC BLOOD PRESSURE;
ADMINISTRATION, ORAL;
ANTIHYPERTENSIVE AGENTS;
BENZIMIDAZOLES;
BIPHENYL COMPOUNDS;
BLOOD PRESSURE;
CLINICAL TRIALS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
HUMANS;
HYPERTENSION;
MALE;
RECEPTOR, ANGIOTENSIN, TYPE 1;
RECEPTOR, ANGIOTENSIN, TYPE 2;
RECEPTORS, ANGIOTENSIN;
SAFETY;
TETRAZOLES;
TREATMENT OUTCOME;
|
|
EID: 0031472678
PISSN: 09521178
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (19)
|
|
References (17)
|
